Chen Pao-Huan, Tsai Shang-Ying, Chiang Shuo-Ju, Hsiao Cheng-Yi, Lin Yen-Kuang, Chung Kuo-Hsuan
Department of Psychiatry, Taipei Medical University Hospital, Taipei, Taiwan; Psychiatric Research Center, Taipei Medical University Hospital, Taipei, Taiwan; Department of Psychiatry, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Department of Psychiatry, Taipei Medical University Hospital, Taipei, Taiwan; Psychiatric Research Center, Taipei Medical University Hospital, Taipei, Taiwan; Department of Psychiatry, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
J Psychiatr Res. 2025 Jan;181:681-688. doi: 10.1016/j.jpsychires.2024.12.023. Epub 2024 Dec 24.
Patients with schizophrenia have a high risk of cardiovascular death. Increased cardiac left ventricular (LV) mass has been reported to be associated with heart failure and cardiac mortality. However, few studies have used echocardiographic imaging to evaluate the associations between cardiac LV mass and the clinical characteristics of schizophrenia. We recruited 121 adults to undergo standard and two-dimensional speckle-tracking echocardiography. Cardiac LV mass was determined using the Devereux formula and indexed with reference to the body surface area to obtain the cardiac LV mass index (LVMI). Clinical and demographic data were obtained through interviews and chart review. The results showed that relative to the mentally healthy controls (n = 55), individuals with schizophrenia (n = 66) had significantly higher mean values of cardiac LVMI as well as lower mitral valve E/A ratio, LV ejection fraction, and LV global longitudinal strain. Among the individuals with schizophrenia, cardiac LVMI was positively correlated with the number of acute episodes, and this association remained significant after adjustment for age, age at onset, and body mass index. On the contrary, there were no significant associations between cardiac LVMI and traditional cardiovascular risk factors. Taken together, this study suggests that the burden of psychotic symptoms may contribute to the increased risk of cardiac hypertrophy in individuals with schizophrenia independent of traditional cardiovascular risk factors. Because cardiac hypertrophy is among the major risk factors of heart failure and cardiac mortality, future research must investigate the mechanisms underlying the association between psychosis and increased cardiac LV mass.
精神分裂症患者有较高的心血管死亡风险。据报道,心脏左心室(LV)质量增加与心力衰竭和心脏死亡率相关。然而,很少有研究使用超声心动图成像来评估心脏左心室质量与精神分裂症临床特征之间的关联。我们招募了121名成年人进行标准和二维斑点追踪超声心动图检查。使用Devereux公式确定心脏左心室质量,并参照体表面积进行指数化以获得心脏左心室质量指数(LVMI)。通过访谈和病历审查获取临床和人口统计学数据。结果显示,相对于心理健康对照组(n = 55),精神分裂症患者(n = 66)的心脏LVMI平均值显著更高,同时二尖瓣E/A比值、左心室射血分数和左心室整体纵向应变更低。在精神分裂症患者中,心脏LVMI与急性发作次数呈正相关,在调整年龄、发病年龄和体重指数后,这种关联仍然显著。相反,心脏LVMI与传统心血管危险因素之间没有显著关联。综上所述,本研究表明,精神症状负担可能导致精神分裂症患者心脏肥大风险增加,且独立于传统心血管危险因素。由于心脏肥大是心力衰竭和心脏死亡率的主要危险因素之一,未来研究必须探究精神病与心脏左心室质量增加之间关联的潜在机制。